Novel Inflammatory Biomarkers in Cardiovascular Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|23|2773-2785

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.23, 2015-01, pp. : 2773-2785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutics in inflammatory bowel disease

By Bernstein Charles N  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1081-1096

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Inflammatory Biomarkers in Cardiovascular Disease: From Molecular Mechanisms to Therapeutic Targets (Part-II))

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2713-2715

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation

By Ong Frank S   Deignan Joshua L   Kuo Jane Z   Bernstein Kenneth E   Rotter Jerome I   Grody Wayne W   Das Kingshuk  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 465-475

Future Medicine

Access to resources Recommend Favorite

Novel Approaches to Anti-Inflammatory Agents as Therapeutics for Asthma

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 9-18

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of Novel Inflammatory Biomarkers in Renal Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2786-2800

Bentham Science Publishers

Access to resources Recommend Favorite